on 31 Dec 1969
Last Applicant/ Owned by
OYSTER POINT PHARMA INC.
202 Carnegie Center, Suite 109Princeton NJ 08540
US
Serial Number
2052237 filed on 10th Aug 2020
Registration Number
TMA1127540 registered on 27th Apr 2022
Registration expiry Date
10th Aug 2030Correspondent Address
1100-150 York StreetToronto
ONTARIO
CA
M5H3S5
Trademark usage description
pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutic Read More11
2052237
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 26 on 14th Jan 2022 | Approved |
Submitted for opposition 27 on 14th Jan 2022 | Approval Notice Sent |
Submitted for opposition 22 on 10th Jan 2022 | Search Recorded |
Submitted for opposition 256 on 19th Jul 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 19th Oct 2020 | Agent Changed |
Submitted for opposition 257 on 17th Sep 2020 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 16th Sep 2020 | Formalized |
Submitted for opposition 1 on 16th Sep 2020 | Created |
Submitted for opposition 228 on 10th Aug 2020 | International Registration |
Submitted for opposition 30 on 10th Aug 2020 | Filed |